NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

OTC Markets · Medical Devices · USD

ENvue Medical, Inc. (FEED) Stock Analysis

ENvue Medical, Inc. (FEED) is a Medical Devices stock listed on OTC Markets and quoted in US Dollar.

Last Updated: October 21, 2026

FEED

$0.30

−$0.20 (−40.05%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare FEED with… →

FEED Key Statistics

As of Oct 21, 2026
Trading
Open
$0.37
Previous Close
$0.50
Day's Range
0.30–0.37
52-Week Range
0.20–73.08
Volume
1.48K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.45
Valuation
Market Cap
$276.84K
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.14
EPS (ttm)Profit attributable to each share over the last twelve months.
−339.36
Financials (FY)
Revenue (FY)
$2.55M−0.20%
Net Income (FY)
−$18.19M
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
923.72K
1-Year Return
−99.58%
Dividend and dates
Avg Volume
83.77K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, FEED closed at $0.30, −99.58% over 1 year.

ENvue Medical, Inc. (FEED) has a market capitalization of $276.84K.

In fiscal 2025, FEED reported revenue of $2.55M.

FEED Stock Return by Calendar Year

ENvue Medical, Inc. (FEED) 10-year return: what $10,000 became

1 year
$10,000 $42
−99.58%
5 years
$10,000 $0.07
−99.999%
10 years
$10,000 $0.02
−99.9998%

If you had invested $10,000 in ENvue Medical, Inc. (FEED) 10 years ago, at the close on October 21, 2016, it would have been worth $0.02 at the close on October 21, 2026: −99.9998% in total, −73.07% a year. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−98.92%
2025−96.44%
2024−48.70%
2023−77.18%
2022−75.77%
2021+36.13%
2020−73.19%
2019−21.29%
2018−22.63%
2017−21.48%
2016 (partial year)+8.36%

As of October 21, 2026.

FEED Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$2.55M−$18.19M−712.3%
2024$2.56M−$3.71M−144.8%
2023$2.28M−$3.71M−162.5%
2022$752.00K−$5.45M−724.5%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$2.55M$153.00K−$11.74M−$18.19M−712.3%
2024$2.56M$1.51M−$3.58M−$3.71M−144.8%
2023$2.28M$1.54M−$3.44M−$3.71M−162.5%
2022$752.00K$167.00K−$5.01M−$5.45M−724.5%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

FEED Valuation vs Medical Devices Median

Median of 145 stocks
MetricFEEDMedical Devices medianvs median
P/S ratio0.142.530.1x the median

Medians across 145 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 12 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values ENvue Medical, Inc. (FEED) at $276.84K. The company sits in the Healthcare sector, in the Medical Devices industry. Headcount on file is 12.

The 52-week range on file runs from $0.20 to $73.08. The most recent close on file for FEED is $0.30, dated October 21, 2026. That is −$0.20 (−40.05%) against the previous close. The latest close sits 49.85% above that 52-week low.

Financial Health

In fiscal 2025, ENvue Medical, Inc. reported revenue of $2.55M. Against the prior fiscal year total of $2.56M, that is a change of −0.20%. The same year closed with a net loss of $18.19M. Trailing earnings per share are −339.36.

Across the 4 fiscal years on file, revenue moves from $752.00K in 2022 to $2.55M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. The price-to-sales ratio is 0.14. On price-to-sales that is 0.1 times the Medical Devices median of 2.53. 145 Medical Devices companies report these metrics, and the medians quoted come from that group.

Beta against the wider market is reported at 1.45. Annualized volatility over the trailing 10 years is 163.01%. Over the trailing twelve months the total return is −99.58%. Measured over 10 years, that is −73.07% a year compounded.

Growth & Income

No dividend is on file for FEED.

So far in 2026 the total return is −98.92%. Across the complete calendar years on file, 2021 returned +36.13% and 2025 returned −96.44%. Of the 9 complete calendar years on file, 1 finished higher.

Peer Comparison

ENvue Medical, Inc. (FEED) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
ENvue Medical, Inc. FEED $276.84K —
Abbott Laboratories ABT $173.92B 32.4
Medtronic plc. MDT $119.00B 22.9
Stryker Corporation SYK $114.15B 30.8

The Medical Devices industry average P/E ratio is 27.1x. ENvue Medical, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$173.92B

 MDT

Medtronic plc.

$119.00B

 SYK

Stryker Corporation

$114.15B

 BSX

Boston Scientific Corporation

$64.33B

 EW

Edwards Lifesciences Corporation

$50.95B

 GEHC

GE HealthCare Technologies Inc.

$31.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About ENvue Medical, Inc.

ENvue Medical, Inc., through its subsidiaries, focuses on non-invasive biological response-activating devices that target biofilm prevention, pain therapy, wound healing, and at home administration without medical professional assistance. Its product portfolio includes UroShield, an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers UroShield Ultra, which is designed to prevent bacterial colonization and biofilm formation in urinary catheters; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures. In addition, it provides PainShield MD, a single patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; PainShield Plus, a dual patch-based therapeutic ultrasound technology; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Europe, Australia, Israel, New Zealand, and internationally. ENvue Medical, Inc. was formerly known as NanoVibronix, Inc. and changed its name to ENvue Medical, Inc. in December 2025. The company was incorporated in 2003 and is based in Tyler, Texas.

Visit website →